Zhang S-L, He Y, Tam KY (2018) Targeting cancer metabolism to develop human lactate dehydrogenase (hLDH)5 inhibitors. Drug Discovery Today 23:1407–1415
Article CAS PubMed Google Scholar
Augoff K, Hryniewicz-Jankowska A, Tabola R (2015) Lactate dehydrogenase 5: an old friend and a new hope in the war on cancer. Cancer Lett 358:1–7
Article CAS PubMed Google Scholar
Rani R, Kumar V (2016) Recent update on human lactate dehydrogenase enzyme 5 (hLDH5) inhibitors: a Promising Approach for Cancer Chemotherapy. J Med Chem 59:487–496
Article CAS PubMed Google Scholar
Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Sci (New York N Y) 324:1029–1033
Buonfiglio R, Ferraro M, Falchi F, Cavalli A, Masetti M, Recanatini M (2013) Collecting and assessing human lactate dehydrogenase-A conformations for structure-based virtual screening. J Chem Inf Model 53:2792–2797
Article CAS PubMed Google Scholar
Kohlmann A, Zech SG, Li F, Zhou T, Squillace RM, Commodore L, Greenfield MT, Lu X, Miller DP, Huang W-S (2013) Fragment growing and linking lead to novel nanomolar lactate dehydrogenase inhibitors. J Med Chem 56:1023–1040
Article CAS PubMed Google Scholar
Kolappan S, Shen DL, Mosi R, Sun J, McEachern EJ, Vocadlo DJ, Craig L (2015) Structures of lactate dehydrogenase A (LDHA) in apo, ternary and inhibitor-bound forms. Acta Crystallogr Sect D: Biol Crystallogr 71:185–195
Boudreau A, Purkey HE, Hitz A, Robarge K, Peterson D, Labadie S, Kwong M, Hong R, Gao M, Del Nagro C, Pusapati R, Ma S, Salphati L, Pang J, Zhou A, Lai T, Li Y, Chen Z, Wei B, Yen I, Sideris S, McCleland M, Firestein R, Corson L, Vanderbilt A, Williams S, Daemen A, Belvin M, Eigenbrot C, Jackson PK, Malek S, Hatzivassiliou G, Sampath D, Evangelista M, O’Brien T (2016) Metabolic plasticity underpins innate and acquired resistance to LDHA inhibition. Nat Chem Biol 12:779–786
Article CAS PubMed Google Scholar
Read J, Winter V, Eszes C, Sessions R, Brady R (2001) Structural basis for altered activity of M-and H‐isozyme forms of human lactate dehydrogenase, proteins: structure, function, and Bioinformatics, 43 175–185
Shi Y, Pinto BM (2014) Human lactate dehydrogenase a inhibitors: a molecular dynamics investigation. PLoS ONE 9:e86365
Article PubMed PubMed Central Google Scholar
Boudreau A, Purkey HE, Hitz A, Robarge K, Peterson D, Labadie S, Kwong M, Hong R, Gao M (2016) Del Nagro, metabolic plasticity underpins innate and acquired resistance to LDHA inhibition. Nat Chem Biol 12:779–786
Article CAS PubMed Google Scholar
Zhou Y, Tao P, Wang M, Xu P, Lu W, Lei P, You Q (2019) Development of novel human lactate dehydrogenase A inhibitors: high-throughput screening, synthesis, and biological evaluations. Eur J Med Chem 177:105–115
Article CAS PubMed Google Scholar
Xiang S, Huang D, He Q, Li J, Tam KY, Zhang SL, He Y (2020) Development of dual inhibitors targeting pyruvate dehydrogenase kinases and human lactate dehydrogenase A: high-throughput virtual screening, synthesis and biological validation. Eur J Med Chem 203:112579
Article CAS PubMed Google Scholar
Rong Y, Wu W, Ni X, Kuang T, Jin D, Wang D, Lou W (2013) Lactate dehydrogenase A is overexpressed in pancreatic cancer and promotes the growth of pancreatic cancer cells. Tumour Biology: J Int Soc Oncodevelopmental Biology Med 34:1523–1530
Hou XM, Yuan SQ, Zhao D, Liu XJ, Wu XA (2019) LDH-A promotes malignant behavior via activation of epithelial-to-mesenchymal transition in lung adenocarcinoma. Biosci Rep, 39
Zhou Y, Niu W, Luo Y, Li H, Xie Y, Wang H, Liu Y, Fan S, Li Z, Xiong W, Li X, Ren C, Tan M, Li G, Zhou M (2019) p53/Lactate dehydrogenase a axis negatively regulates aerobic glycolysis and tumor progression in breast cancer expressing wild-type p53. Cancer Sci 110:939–949
Article CAS PubMed PubMed Central Google Scholar
Koukourakis MI, Giatromanolaki A, Sivridis E, Gatter KC, Harris AL (2006) Lactate dehydrogenase 5 expression in operable colorectal cancer: strong association with survival and activated vascular endothelial growth factor pathway–a report of the Tumour Angiogenesis Research Group. J Clin Oncology: Official J Am Soc Clin Oncol 24:4301–4308
Mohajertehran F, Ayatollahi H, Jafarian AH, Khazaeni K, Soukhtanloo M, Shakeri MT, Mohtasham N (2019) Overexpression of Lactate dehydrogenase in the saliva and tissues of patients with Head and Neck squamous cell carcinoma. Rep Biochem Mol Biology 7:142–149
Zhuang L, Scolyer RA, Murali R, McCarthy SW, Zhang XD, Thompson JF, Hersey P (2010) Lactate dehydrogenase 5 expression in melanoma increases with disease progression and is associated with expression of Bcl-XL and Mcl-1, but not Bcl-2 proteins. Mod Pathology: Official J United States Can Acad Pathol Inc 23:45–53
Zhao J, Huang X, Xu Z, Dai J, He H, Zhu Y, Wang H (2017) LDHA promotes tumor metastasis by facilitating epithelial–mesenchymal transition in renal cell carcinoma. Mol Med Rep 16:8335–8344
Article CAS PubMed Google Scholar
Fantin VR, St-Pierre J, Leder P (2006) Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell 9:425–434
Article CAS PubMed Google Scholar
Le A, Cooper CR, Gouw AM, Dinavahi R, Maitra A, Deck LM, Royer RE, Vander Jagt DL, Semenza GL, Dang CV (2010) Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression. Proc Natl Acad Sci USA 107:2037–2042
Article CAS PubMed PubMed Central Google Scholar
Thornburg JM, Nelson KK, Clem BF, Lane AN, Arumugam S, Simmons A, Eaton JW, Telang S, Chesney J (2008) Targeting aspartate aminotransferase in breast cancer. Breast cancer Research: BCR 10:R84
Article PubMed PubMed Central Google Scholar
Granchi C, Roy S, Giacomelli C, Macchia M, Tuccinardi T, Martinelli A, Lanza M, Betti L, Giannaccini G, Lucacchini A, Funel N, León LG, Giovannetti E, Peters GJ, Palchaudhuri R, Calvaresi EC, Hergenrother PJ, Minutolo F (2011) Discovery of N-hydroxyindole-based inhibitors of human lactate dehydrogenase isoform A (LDH-A) as starvation agents against cancer cells. J Med Chem 54:1599–1612
Article CAS PubMed Google Scholar
Billiard J, Dennison JB, Briand J, Annan RS, Chai D, Colón M, Dodson CS, Gilbert SA, Greshock J, Jing J, Lu H, McSurdy-Freed JE, Orband-Miller LA, Mills GB, Quinn CJ, Schneck JL, Scott GF, Shaw AN, Waitt GM, Wooster RF, Duffy KJ (2013) Quinoline 3-sulfonamides inhibit lactate dehydrogenase A and reverse aerobic glycolysis in cancer cells. Cancer Metabolism 1:19
Article PubMed PubMed Central Google Scholar
Fradera X, Babaoglu K (2017) Overview of methods and strategies for conducting virtual small molecule screening. Curr Protocols Chem Biology 9:196–212
Forli S (2015) Charting a path to success in virtual screening. Molecules 20:18732–18758
Article CAS PubMed PubMed Central Google Scholar
McInnes C (2007) Virtual screening strategies in drug discovery. Curr Opin Chem Biol 11:494–502
Article CAS PubMed Google Scholar
Truchon JF, Bayly CI (2007) Evaluating virtual screening methods: good and bad metrics for the early recognition problem. J Chem Inf Model 47:488–508
Article CAS PubMed Google Scholar
Kontoyianni M (2017) Docking and virtual screening in Drug Discovery, methods in molecular biology. (Clifton N J) 1647:255–266
Kitchen DB, Decornez H, Furr JR, Bajorath J (2004) Docking and scoring in virtual screening for drug discovery: methods and applications, Nature reviews. Drug Discovery 3:935–949
Article CAS PubMed Google Scholar
Bitencourt-Ferreira G, Veit-Acosta M, de Azevedo, Jr. WF (2019) Hydrogen bonds in protein-ligand complexes. Methods Mol Biology (Clifton N J) 2053:93–107
Ding J, Gumpena R, Boily M O, Caron A, Chong O, H Cox J, Dumais V, Gaudr
留言 (0)